Randomized controlled study on the prevention of osteoporotic fractures (OF study): A phase IV clinical study of 15-mg menatetrenone capsules

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 1, 2009, Pages 66-75

  Inoue, Tetsuo ^a   Fujita, Toshiharu ^b   Kishimoto, Hideaki ^c   Makino, Toshitaka ^d   Nakamura, Tetsuro ^e   Nakamura, Toshitaka ^f   Sato, Tosiya ^g   Yamazaki, Kaoru ^h  

^a Aoyama General Hospital   (Japan)

^b INSTITUTE OF STATISTICAL MATHEMATICS   (Japan)

^c SAN IN ROSAI HOSPITAL   (Japan)

^d Japan Cosmetic Industry Association   (Japan)

^e University of Tokyo   (Japan)

^f UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^g KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

^h HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ADL; Controlled study; Fractures; Menatetrenone; Osteoporosis

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; MENATETRENONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRAGILITY FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MONOTHERAPY; OSTEOPOROSIS; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FEMALE; HEMOSTATICS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; SPINAL FRACTURES; VITAMIN K 2;

EID: 58149186456     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0008-8     Document Type: Article

References (32)

1. JH Bouckaert AH Said 1960 Fracture healing by vitamin K Nature (Lond) 185 849
2. J Stenflo P Fernlund W Egan P Roepstorff 1974 Vitamin K dependent modification of glutamic acid residues in prothrombin Proc Natl Acad Sci USA 71 2730 2733
3. PV Hauschka JB Lian PM Gallop 1975 Direct identification of the calcium-binding amino acid, γ-carboxyglutamate, in mineralized tissue Proc Natl Acad Sci USA 72 3925 3929
4. PA Price AS Otsuka JW Poser J Kristaponis N Raman 1976 Characterization of a γ-carboxyglutamic acid-containing protein from bone Proc Natl Acad Sci USA 73 1447 1451
5. 2 (menatetrenone) on bone resorption may be related to its side chain Bone (NY) 16 179 184
6. 2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro J Bone Miner Res 12 431 438
7. 1 in osteoporosis J Clin Endocrinol Metab 60 268 1269
8. L Bitensky JP Hart A Catterall SJ Hodges MJ Pilkington 1988 Circulating vitamin K levels in patients with fractures J Bone Joint Surg 70 663 664
9. 2 decreased in elderly women with hip fracture J Bone Miner Res 10 1241 1245
10. P Szulc MC Chapuy PJ Meunier PD Delmas 1993 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women J Clin Invest 91 1769 1774
11. H Orimo Y Hayashi M Fukunaga T Sone S Fujiwara 2001 Diagnostic criteria for primary osteoporosis: year 2000 revision J Bone Miner Metab 19 331 337
12. T Inoue K Kushida S Miyamoto Y Sumi H Orimo 1983 Quantitative assessment of bone density on X-ray picture J Jpn Orthop Assoc 57 1923 1936
13. H Orimo T Fujita T Onomura T Inoue K Kushida 1992 Clinical evaluation of Ea-0167 (menatetrenone) in the treatment of osteoporosis: phase III double-blind multicenter comparative study with alfacalcidol Clin Eval 20 45 100
14. Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lippincott-Raven, Philadelphia
15. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis Calcif Tissue Int 54 370 376
16. MW Tilyard GFS Spears J Thomson S Dovey 1992 Treatment of postmenopausal osteoporosis with calcitriol or calcium N Engl J Med 326 357 362
17. JF Aloia A Vaswani JK Yeh K Ellis S Yasumura 1988 Calcitriol in the treatment of postmenopausal osteoporosis Am J Med 84 401 408
18. JC Gallagher BL Riggs RR Recker D Goldgar 1989 The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency (42922) Proc Soc Exp Biol 191 287 292
19. The European Prospective Osteoporosis Study (EPOS) Group 2002 Incidence of vertebral fracture in Europe: results from the European prospective osteoporosis study (EPOS) J Bone Miner Res 17 716 724
20. S Fujiwara F Kasagi N Masunari K Naito G Suzuki 2003 Fracture prediction from bone mineral density in Japanese men and women J Bone Miner Res 18 1547 1553
21. 3 J Bone Miner Metab 10 184 188
22. ST Harris NB Watts HK Genant CD McKeever T Hangartner 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial JAMA 282 1344 1352
23. J-Y Reginster HW Minne OH Sorensen M Hooper C Roux 2000 Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis Osteoporos Int 11 83 91
24. S Cockayne J Adamson S Lanham-New M Shearer S Gilbody 2006 Vitamin K and the prevention of fractures Arch Intern Med 166 1256 1261
25. 2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women Osteoporos Int 18 963 972
26. K Kushida M Fukunaga H Kishimoto M Shiraki A Itabashi 2004 A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial J Bone Miner Metab 22 469 478
27. L Plantalech M Guillaumont P Vergnaud M Leclercq PD Delmas 1991 Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women J Bone Miner Res 6 1211 1216
28. N Tsugawa M Shiraki Y Suhara M Kamao K Tanaka 2006 Vitamin K status of healthy Japanese women: age-related vitamin K requirement for γ-carboxylation of osteocalcin Am J Clin Nutr 83 380 386
29. PD Ross S Fujiwara C Huang JW Davis RS Epstein 1995 Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US Int J Epidemiol 24 1171 1177
30. H Jinbayashi K Aoyagi PD Ross M Ito H Shindo 2002 Prevalence of vertebral deformity and its associations with physical impairment among Japanese women: the Hizen-Oshima study Osteoporos Int 13 723 730
31. Lipid Research Clinical Program 1984 The lipid research clinical coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease JAMA 251 351 364
32. H Nakamura K Arakawa H Itakura A Kitabatake Y Goto 2006 Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial Lancet 368 1155 1163